Call for Papers

Article List

Editorial [Hot Topic: Novel Factor Xa-and Thrombin-Inhibitors (Executive Editor: Giuseppe G. Nenci)]
[ Vol. 11 , Issue. 30 ]
Author(s): Giuseppe G. Nenci
Pages: 3853-3854 (2)
Heterogeneity of Synthetic Factor Xa Inhibitors
[ Vol. 11 , Issue. 30 ]
Author(s): G. T. Gerotziafas and M. M. Samama
Pages: 3855-3876 (22)
Pharmacology and Clinical Potential of Direct Thrombin Inhibitors
[ Vol. 11 , Issue. 30 ]
Author(s): L- A. Linkins and J. I. Weitz
Pages: 3877-3884 (8)
Direct Thrombin Inhibitors for the Prevention of Venous Thromboembolism after Major Orthopaedic Surgery
[ Vol. 11 , Issue. 30 ]
Author(s): G. Agnelli, F. Sonaglia and C. Becattini
Pages: 3885-3891 (7)
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism
[ Vol. 11 , Issue. 30 ]
Author(s): A. Iorio, F. Guercini, F. Ferrante and G. G. Nenci
Pages: 3893-3918 (26)
Direct Thrombin Inhibitors for the Treatment of Acute Coronary Syndromes and During Percutaneous Coronary Interventions
[ Vol. 11 , Issue. 30 ]
Author(s): G. Paoli, P. A. Merlini and D. Ardissino
Pages: 3919-3929 (11)
Direct Thrombin Inhibitors for Treatment of Heparin Induced Thrombocytopenia, Deep Vein Thrombosis and Atrial Fibrillation
[ Vol. 11 , Issue. 30 ]
Author(s): C. W. Francis
Pages: 3931-3941 (11)
Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis
[ Vol. 11 , Issue. 30 ]
Author(s): M. Gharaee-Kermani and S. H. Phan
Pages: 3943-3971 (29)
Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
[ Vol. 11 , Issue. 30 ]
Author(s): M. Buemi, C. Aloisi, F. Fulvio, C. Caccamo, E. Cavallaro, E. Crasci, M. Criseo, F. Corica and N. Frisina
Pages: 3973-3984 (12)